Document is current
Any future updates will be listed below
-
Authors
Iwata, Mari
Iwamoto, Kunihiro https://orcid.org/0000-0003-3868-3372
Kitajima, Iwao
Nogi, Takasuke
Onishi, Koichi
Kajiyama, Yu
Nishino, Izumi
Ando, Masahiko
Ozaki, Norio
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP20mk0101137h0002)
Ministry of Education, Culture, Sports, Science and Technology of Japan
Ministry of Health, Labour and Welfare of Japan
Japan Science and Technology Agency.
- License Information
-
More Information
Article History
Received: 9 August 2020
Accepted: 18 November 2020
First Online: 24 November 2020
Compliance with ethical standards
:
: MI has no conflicts of interest to declare. KI has received speakers’ honoraria from or has served as a consultant to Dainippon Sumitomo, Janssen, Meiji Seika Pharma, Mochida, Otsuka, Taisho, Towa, and Pfizer. IK, TN, KO, YK and IN are employees of Taisho Pharmaceutical Co., Ltd., Japan. MA has received subsidies from Kyowa Kirin. NO has received research support or speakers’ honoraria from or has served as a consultant to Abbvie, Asahi Kasei Pharma, Astellas, Dainippon Sumitomo, Eisai, Eli Lilly, GlaxoSmithKline, Janssen, Meiji Seika Pharma, Mochida, MSD, Novartis Pharma, Ono, Otsuka, Pfizer, Shionogi, Takeda, Tanabe Mitsubishi, Sanofi, and Yoshitomi.
